InBioGen Co (101140.KS) Stock Price

InBioGen Co Price

CLOSED
4,960.00
​
Market closed

Revenue at InBioGen Co has contracted by 6.8% per year over the past 17 years to 6.30 B KRW. Earnings per share have grown at 4.2% per year over the last 15 years. For InBioGen Co, the net margin of -22.5% is down versus 898.1% a few years ago.

InBioGen Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InBioGen Co business model & stock analysis

INBIOGEN CO., Ltd. generates revenue through four distinct business segments, leveraging its manufacturing and sales capabilities across diverse markets. The Kiosk Business segment operates unmanned payment machines within restaurants, karaoke rooms, and personal computer rooms, providing automated transaction solutions for these specific venues. This segment capitalizes on the demand for efficient, contactless payment infrastructure in high-traffic entertainment and dining areas. The Footwear Business segment focuses on the sale of children's shoes and adult shoes, serving consumers seeking specific apparel categories. Complementing this, the Wood Pellet Business segment sells wood pellets and sawdust, addressing energy or industrial material needs. These two segments represent the core physical product offerings of the company, targeting different consumer and industrial bases respectively. Additionally, the Other Business segment engages in online and offline education to foster human resources in the FinTech service, platform business, and block chain industry. This educational arm targets individuals and professionals seeking skills in emerging financial technologies. By combining physical goods with specialized training services, INBIOGEN CO., Ltd. diversifies its income streams across technology, retail, energy, and education sectors.

Frequently asked questions about InBioGen Co

Converted at the current exchange rate, the InBioGen Co share trades at 3.32 EUR (4,960.00 KRW).

The revenue cannot currently be calculated for InBioGen Co.

The profit cannot currently be calculated for InBioGen Co.

The P/E ratio cannot be calculated for InBioGen Co at the moment.

The P/S cannot be calculated for InBioGen Co currently.

The Eulerpool Quality Score for InBioGen Co is 1/10.

The ISIN of InBioGen Co is KR7101140002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of InBioGen Co is 101140.KS. The ticker symbol is used to trade InBioGen Co shares on the stock exchange.

Fair ValueTerminal
4,166.40 KRW
Over-/UndervaluationTerminal
Fairly valued
Industry
Textiles, Apparel & Luxury Goods
Number of shares
Employees
Revenue per Employee
174.91 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Apr 2, 2008
ISIN
KR7101140002
Cusip
Y0R08L109
Market capitalization
49.52 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
0.31
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-0.90 %
Last updated Oct 20, 2026, 9:30 PM

InBioGen Co Peer Group

InBioGen Co FIGI

101140:KS · BBG000V0TP25101140:KP · BBG000V0TPL4

All fundamentals and in-depth analysis of InBioGen Co

Our stock analysis for InBioGen Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InBioGen Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.